Abstract 20: Raf kinase inhibitors can induce Raf dimerization, downstream signaling, and cell growth
Tobi Nagel, Darrin D. Stuart(Proteostasis Therapeutics (United States)), Hanne Merritt, Daniel Poon(Rapt Therapeutics (United States)), Yongjin Xu, John E. Tellew(Genomics Institute of the Novartis Research Foundation), Marco Wallroth, B.A. Appleton(Novartis (Switzerland)), Kevin Shoemaker, John S.D. Chan(Centre Hospitalier de l’Université de Montréal), Nanxin Li(Genomics Institute of the Novartis Research Foundation), Susan Kaufman(Genesys (United States)), Matthew Holderfield(Revolution Medicines (United States))
Cited by 2
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
Attitudes and perceptions of UK medical students towards artificial intelligence and radiology: a multicentre survey
|Insights into Imaging|2020|492
Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> Activity
|ChemMedChem|2019|193